NCT01172821View on ClinicalTrials.gov

Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma II

PHASE3CompletedINTERVENTIONAL
Enrollment

1,032

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Asthma
Interventions
DRUG

placebo

Placebo that represents BI drug

DRUG

placebo

Placebo that represents comparator

DRUG

placebo

Placebo that represents comparator

DRUG

tiotropium Respimat® low dose

IMP

DRUG

placebo

Placebo that represents BI drug

DRUG

tiotropium Respimat® high dose

IMP

DRUG

50 mcg salmeterol HFA MDI

Active comparator

DRUG

placebo

Placebo that represents comparator

Trial Locations (125)

Unknown

205.419.01058 Boehringer Ingelheim Investigational Site, Los Angeles

205.419.01053 Boehringer Ingelheim Investigational Site, Stockton

205.419.01061 Boehringer Ingelheim Investigational Site, Centennial

205.419.01066 Boehringer Ingelheim Investigational Site, Denver

205.419.01064 Boehringer Ingelheim Investigational Site, Panama City

205.419.01060 Boehringer Ingelheim Investigational Site, Winter Park

205.419.01068 Boehringer Ingelheim Investigational Site, Novi

205.419.01054 Boehringer Ingelheim Investigational Site, Plymouth

205.419.01062 Boehringer Ingelheim Investigational Site, St Louis

205.419.01070 Boehringer Ingelheim Investigational Site, Bozeman

205.419.01067 Boehringer Ingelheim Investigational Site, Skillman

205.419.01071 Boehringer Ingelheim Investigational Site, Raleigh

205.419.01055 Boehringer Ingelheim Investigational Site, Cincinnati

205.419.01065 Boehringer Ingelheim Investigational Site, Portland

205.419.01069 Boehringer Ingelheim Investigational Site, Greenville

205.419.01056 Boehringer Ingelheim Investigational Site, Union

205.419.01063 Boehringer Ingelheim Investigational Site, El Paso

205.419.01051 Boehringer Ingelheim Investigational Site, San Antonio

205.419.55053 Boehringer Ingelheim Investigational Site, Florianópolis

205.419.55054 Boehringer Ingelheim Investigational Site, Porto Alegre

205.419.55052 Boehringer Ingelheim Investigational Site, São Paulo

205.419.55055 Boehringer Ingelheim Investigational Site, São Paulo

205.419.86061 Boehringer Ingelheim Investigational Site, Chengdu

205.419.86053 Boehringer Ingelheim Investigational Site, Chongqing

205.419.86056 Boehringer Ingelheim Investigational Site, Guangzhou

205.419.86062 Boehringer Ingelheim Investigational Site, Guangzhou

205.419.86054 Boehringer Ingelheim Investigational Site, Haikou

205.419.86059 Boehringer Ingelheim Investigational Site, Kunming

205.419.86058 Boehringer Ingelheim Investigational Site, Nanchang

205.419.86064 Boehringer Ingelheim Investigational Site, Nanjing

205.419.86051 Boehringer Ingelheim Investigational Site, Shanghai

205.419.86052 Boehringer Ingelheim Investigational Site, Shanghai

205.419.86055 Boehringer Ingelheim Investigational Site, Shanghai

205.419.86066 Boehringer Ingelheim Investigational Site, Shanghai

205.419.86057 Boehringer Ingelheim Investigational Site, Xi'an

205.419.86065 Boehringer Ingelheim Investigational Site, Xi'an

205.419.86063 Boehringer Ingelheim Investigational Site, Xuzhou

205.419.86067 Boehringer Ingelheim Investigational Site, Yangzhou

205.419.86068 Boehringer Ingelheim Investigational Site, Yinchuan

205.419.57051 Boehringer Ingelheim Investigational Site, Bogotá

205.419.57052 Boehringer Ingelheim Investigational Site, Bogotá

205.419.57053 Boehringer Ingelheim Investigational Site, Bogotá

205.419.57054 Boehringer Ingelheim Investigational Site, Medellín

205.419.49061 Boehringer Ingelheim Investigational Site, Bamberg

205.419.49051 Boehringer Ingelheim Investigational Site, Berlin

205.419.49052 Boehringer Ingelheim Investigational Site, Berlin

205.419.49062 Boehringer Ingelheim Investigational Site, Berlin

205.419.49063 Boehringer Ingelheim Investigational Site, Berlin

205.419.49064 Boehringer Ingelheim Investigational Site, Berlin

205.419.49054 Boehringer Ingelheim Investigational Site, Frankfurt

205.419.49058 Boehringer Ingelheim Investigational Site, Hamburg

205.419.49057 Boehringer Ingelheim Investigational Site, Koblenz

205.419.49056 Boehringer Ingelheim Investigational Site, Lübeck

205.419.49059 Boehringer Ingelheim Investigational Site, Rüdersdorf

205.419.49053 Boehringer Ingelheim Investigational Site, Wiesbaden

205.419.49055 Boehringer Ingelheim Investigational Site, Witten

205.419.91057 Boehringer Ingelheim Investigational Site, Ahmedabad

205.419.91056 Boehringer Ingelheim Investigational Site, Coimbatore

205.419.91055 Boehringer Ingelheim Investigational Site, Hyderabad

205.419.91051 Boehringer Ingelheim Investigational Site, Jaipur

205.419.91058 Boehringer Ingelheim Investigational Site, Jaipur

205.419.91054 Boehringer Ingelheim Investigational Site, Mumbai

205.419.91059 Boehringer Ingelheim Investigational Site, Mysore

205.419.91053 Boehringer Ingelheim Investigational Site, Nagpur

205.419.81085 Boehringer Ingelheim Investigational Site, Aira, Kagoshima

205.419.81062 Boehringer Ingelheim Investigational Site, Chuo-ku, Tokyo

205.419.81073 Boehringer Ingelheim Investigational Site, Fukuoka, Fukuoka

205.419.81074 Boehringer Ingelheim Investigational Site, Fukuoka, Fukuoka

205.419.81072 Boehringer Ingelheim Investigational Site, Fukuyama, Hiroshima

205.419.81069 Boehringer Ingelheim Investigational Site, Habikino, Osaka

205.419.81071 Boehringer Ingelheim Investigational Site, Hiroshima, Hiroshima

205.419.81058 Boehringer Ingelheim Investigational Site, Itabashi-ku, Tokyo

205.419.81064 Boehringer Ingelheim Investigational Site, Iwata, Shizuoka

205.419.81063 Boehringer Ingelheim Investigational Site, Kanazawa, Ishikawa

205.419.81054 Boehringer Ingelheim Investigational Site, Kishiwada, Osaka

205.419.81075 Boehringer Ingelheim Investigational Site, Kitakyushu, Fukuoka

205.419.81070 Boehringer Ingelheim Investigational Site, Kobe, Hyogo

205.419.81061 Boehringer Ingelheim Investigational Site, Koto-ku, Tokyo

205.419.81067 Boehringer Ingelheim Investigational Site, Kyoto, Kyoto

205.419.81080 Boehringer Ingelheim Investigational Site, Matsusaka, Mie

205.419.81081 Boehringer Ingelheim Investigational Site, Meguro-ku, Tokyo

205.419.81060 Boehringer Ingelheim Investigational Site, Minato-ku, Tokyo

205.419.81077 Boehringer Ingelheim Investigational Site, Minato-ku, Tokyo

205.419.81056 Boehringer Ingelheim Investigational Site, Morioka, Iwate

205.419.81055 Boehringer Ingelheim Investigational Site, Naka-gun, Ibaraki

205.419.81078 Boehringer Ingelheim Investigational Site, Nakano-ku,Tokyo

205.419.81084 Boehringer Ingelheim Investigational Site, Oita,Oita

205.419.81068 Boehringer Ingelheim Investigational Site, Osaka-Sayama, Osaka

205.419.81053 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido

205.419.81057 Boehringer Ingelheim Investigational Site, Sendai, Miyagi

205.419.81059 Boehringer Ingelheim Investigational Site, Seto, Aichi

205.419.81082 Boehringer Ingelheim Investigational Site, Shinagawa-ku, Tokyo

205.419.81065 Boehringer Ingelheim Investigational Site, Shizuoka, Shizuoka

205.419.81066 Boehringer Ingelheim Investigational Site, Toyota, Aichi

205.419.81051 Boehringer Ingelheim Investigational Site, Urasoe, Okinawa

205.419.81052 Boehringer Ingelheim Investigational Site, Urasoe, Okinawa

205.419.81076 Boehringer Ingelheim Investigational Site, Urasoe, Okinawa

205.419.81083 Boehringer Ingelheim Investigational Site, Yokohama, Kanagawa

205.419.81079 Boehringer Ingelheim Investigational Site, Yotsukaido, Chiba

205.419.52051 Boehringer Ingelheim Investigational Site, Mexico City

205.419.52052 Boehringer Ingelheim Investigational Site, Mexico City

205.419.52053 Boehringer Ingelheim Investigational Site, Monterrey

205.419.51051 Boehringer Ingelheim Investigational Site, Lima

205.419.51052 Boehringer Ingelheim Investigational Site, Lima

205.419.51053 Boehringer Ingelheim Investigational Site, Lima

205.419.51054 Boehringer Ingelheim Investigational Site, Lima

205.419.51055 Boehringer Ingelheim Investigational Site, Lima

205.419.48052 Boehringer Ingelheim Investigational Site, Bialystok

205.419.48054 Boehringer Ingelheim Investigational Site, Bydgoszcz

205.419.48055 Boehringer Ingelheim Investigational Site, Gorzów Wielkopolski

205.419.48051 Boehringer Ingelheim Investigational Site, Krakow

205.419.48057 Boehringer Ingelheim Investigational Site, Poznan

205.419.48058 Boehringer Ingelheim Investigational Site, Sopot

205.419.48056 Boehringer Ingelheim Investigational Site, Wroclaw

205.419.48053 Boehringer Ingelheim Investigational Site, Włoszczowa

205.419.40055 Boehringer Ingelheim Investigational Site, Brasov

205.419.40056 Boehringer Ingelheim Investigational Site, Brasov

205.419.40051 Boehringer Ingelheim Investigational Site, Bucharest

205.419.40052 Boehringer Ingelheim Investigational Site, Bucharest

205.419.40053 Boehringer Ingelheim Investigational Site, Bucharest

205.419.40054 Boehringer Ingelheim Investigational Site, Bucharest

205.419.40058 Boehringer Ingelheim Investigational Site, Bucharest

205.419.40060 Boehringer Ingelheim Investigational Site, Bucharest

205.419.40059 Boehringer Ingelheim Investigational Site, Constanța

205.419.40057 Boehringer Ingelheim Investigational Site, Iași

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY